Abstract
Purpose
The role of thyroid function in biochemical markers of first trimester screening has not been assessed. The aim of the present study was to investigate if there were any relation between maternal thyroid hormones and free-beta subunit of human chorionic gonadotropin (fβ-hCG) and pregnancy-associated plasma protein A (PAPP-A) levels as the biochemical markers of the combined first trimester aneuploidy screening.
Methods
375 pregnant women between 11 and 14 weeks of gestation who were offered routine first trimester prenatal aneuploidy screening and whose thyroid hormone levels (Thyroid stimulating hormone (TSH), free and total thyroxine, free and total triiodothyronine, anti thyroid peroxidase antibody) were measured were assessed. Correlation of free-β-hCG and PAPP-A with maternal thyroid hormones was analyzed.
Results
There was no statistically significant correlation between maternal TSH, free and total thyroxine, free and total triiodothyronine, anti-thyroid peroxidase antibodies and free-β-hCG and PAPP-A as biochemical markers of first trimester aneuploidy screening.
Conclusion
Maternal thyroid function does not seem to affect secretion of fβ-hCG and PAPP-A.
Similar content being viewed by others
References
Wald NJ, Watt HC, Hackshaw AK (1999) Integrated screening for Down’s syndrome based on tests performed during the first and second trimesters. N Engl J Med 341:461–467
Hershman JM (2004) Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metab 18:249–265
Kayisli UA, Selam B, Guzeloglu-Kayisli O, Demir R, Arici A (2003) Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J Immunol 171:2305–2313
Glinoer D, de Nayer P, Bourdoux P, Lemone M, Robyn C, van Steirteghem A, Kinthaert J, Lejeune B (1990) Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 71:276–287
Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH (2008) Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod 23:1968–1975
Bonno M, Oxvig C, Kephart GM, Wagner JM, Kristensen T, Sottrup-Jensen L, Gleich GJ (1994) Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest 71:560–566
Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR 3rd, Conover CA (1999) The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96:3149–3153
Giudice LC, Conover CA, Bale L, Faessen GH, Ilg K, Sun I, Imani B, Suen LF, Irwin JC, Christiansen M et al (2002) Identification and regulation of IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J Clin Endocrinol Metab 87:2359–2366
Spencer K, Aitken DA, Crossley JA, McCaw G, Berry E, Anderson R, Connor JM, Macri JN (1994) First trimester biochemical screening for trisomy 21: the role of free β hCG, a fetoprotein and pregnancy associated plasma protein A. Ann Clin Biochem 31:447–454
Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM (2002) Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intraunterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 87:1762–1767
Spencer Kevin, Cowans Nicholas J, Nicolaides Kypros H (2008) Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 28:7–10
Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA, Désilets VA, Johnson JA, Langlois S, Summers A, Wyatt P (2008) Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can 30:918–949
Guibourdenche J, Frendo JL, Pidoux G, Bertin G, Luton D, Muller F, Porquet D, Evain-Brion D (2003) Expression of pregnancy-associated plasma protein-A (PAPP-A) during human villous trophoblast differentiation in vitro. Placenta 24:532–539
Calvo RM, Jauniaux E, Gulbis B, Asunción M, Gervy C, Contempré B, Morreale de Escobar G (2002) Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 87:1768–1777
Maruo T, Matsuo H, Mochizuki M (1991) Thyroid hormone as a biological amplifier of differentiated trophoblast function in early pregnancy. Acta Endocrinol (Copenh) 125:58–66
Näntö-Salonen K, Muller HL, Hoffman AR, Vu TH, Rosenfeld RG (1993) Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated. Endocrinology 132:781–788
Ardawi MS, Nasrat HA, Rouzi AA, Qari MH, Al-Qahtani MH, Abuzenadah AM (2007) Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10–13(+6) weeks in relation to co-variables in pregnant Saudi women. Prenat Diagn 27:303–311
Spencer K, Bindra R, Nicolaides KH (2003) Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 23:851–855
Spencer K, Heath V, El-Sheikhah A, Ong CY, Nicolaides KH (2005) Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental. Asian and Afro-Caribb popul Prenat Diagn 25:365–369
Spencer K, Bindra R, Cacho AM, Nicolaides KH (2004) The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 24:169–173
Ashoor G, Kameta NA, Akolekar R, Guisado J, Nicolaides KH (2010) Maternal thyroid function at 11–13 weeks of gestation. Fetal Diagn Ther 27:156–163
Bottazzi C, Demori I, Leone M, Fugassa E (1996) Thyroid hormone affects rat uterine expression of IGF-I and IGFBP-4. Boll Soc Ital Biol Sper 72:133–138
Prummel MF, Wiersinga WM (2004) Thyroid autoimmunity and miscarriage. Eur J Endocrinol 150:751–755
Mestman JH (1999) Thyroid and pregnancy. In: Weikle WA (ed) Hormone replacement therapy. Humana Press, San Diego, pp 119–142
Weinans MJ, Pratt JJ, de Wolf BT, Mantingh A (2001) First-trimester maternal serum human thyroid-stimulating hormone in chromosomally normal and Down syndrome pregnancies. Prenat Diagn 21:723–725
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aytan, H., Caliskan, A.C., Demirturk, F. et al. Relationship between maternal thyroid hormones and the biochemical markers of the first trimester aneuploidy screening. Arch Gynecol Obstet 287, 1125–1129 (2013). https://doi.org/10.1007/s00404-013-2712-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-013-2712-4